National Health Investors is close to an area that might stop the downward trend.

Fundamentally, there is a +15% potential to reach the consensus average target price. EPS estimates were upward revised over the last 12 months. Growth forecast are encouraging and the stock offers a good yield, near 5%.

Technically, the security is in a consolidation area limited by the 65.2 support and the USD 76.5 resistance. Above the lower limit, investors should stay optimistic. The stock is current evolving near a significant support.
Consequently, investors may open a long position at current prices and target a reversal toward the USD 72.35 pivot point. A stop loss order should be set at USD 62.